De Boer, M. et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N. Engl. J. Med. 361, 653–663 (2009).
Sentinel-node biopsy can detect micrometastases or isolated tumor cells in the regional lymph nodes of patients with breast cancer; however, whether the presence of very low numbers of metastatic cells influences the outcome in these patients is currently unclear. De Boer and colleagues carried out a study to investigate the relationship between the presence of isolated tumor cells or micrometastases in regional lymph nodes and clinical outcome in patients with breast cancer who had undergone sentinel-node biopsy.
The authors used The Netherlands Cancer Registry to identify women with invasive breast cancer who had undergone sentinel-node biopsy before 2006 and had favorable primary tumor characteristics. Three cohorts were included in the analysis: node-negative patients who did not receive systemic adjuvant therapy (n = 856), node-positive patients who did not receive adjuvant therapy (n = 856) and node-positive patients who received systemic adjuvant therapy (n = 995). The primary end point was 5-year disease-free survival.
After a median follow-up of 5.1 years, the hazard ratio for disease recurrence was 1.50 in patients with isolated tumor cells who received no systemic treatment compared with patients in the node-negative, no-adjuvant-treatment group. The hazard ratio was 1.56 for patients with micrometastases. Analysis of the effect of systemic adjuvant therapy on outcome in patients with micrometastases or isolated tumor cells gave a hazard ratio of 0.57 in patients who received adjuvant therapy versus those who did not.
The authors conclude that the presence of isolated tumor cells or micrometastases is associated with a reduction in 5-year disease-free survival in women who do not receive adjuvant therapy. Disease-free survival was improved in node-positive women who were treated with adjuvant therapy.
Rights and permissions
About this article
Cite this article
Aujla, M. Micrometastases and breast cancer. Nat Rev Clin Oncol 6, 616 (2009). https://doi.org/10.1038/nrclinonc.2009.157
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2009.157